| Literature DB >> 29291402 |
Jun Zhao1, Xiang Xiang1, Hongxia Zhang1, Dengzhi Jiang1, Yidan Liang1, Wang Qing1, Liu Liu1, Qing Zhao1, Zhaohui He2.
Abstract
The endoplasmic reticulum stress-related factor CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP) aggravates early brain injury (EBI) in rats after subarachnoid hemorrhage (SAH). Our research aims to investigate the role of CHOP-mediated iron metabolism in EBI after SAH and the underlying mechanism. Male Sprague-Dawley rats were used to establish SAH models. Tunicamycin (Tm) was employed to excite CHOP expression, and two CHOP small interfering RNAs (siRNAs) were used to inhibit CHOP expression. Neurological scores, brain water content, and blood-brain barrier (BBB) permeability were evaluated at 24h after SAH. Western blotting and immunofluorescence were implemented for the quantification and localization of GRP78 (glucoseregulated protein78), CHOP, C/EBPα (CCAAT/enhancer binding proteinα) and hepcidin. Apoptotic cells were detected by TUNEL staining, and the brain iron content was measured via Perls' staining. The expression of CHOP and hepcidin increased and the expression of C/EBPα decreased after SAH. Knockdown of CHOP decreased the brain water content, reduced Evans blue extravasation, and improved neurological functions. CHOP significantly increased hepcidin levels and significantly decreased C/EBPα levels after SAH. Hepcidin is expressed in the nuclei of neurons and is widely co-localized with TUNEL-positive cells both in the hippocampus and cortex. Along with increased hepcidin expression, the iron content in brain tissue and the apoptosis rate were increased. Thus, CHOP promotes hepcidin expression by regulating C/EBPα activity, which increases the brain iron content, induces apoptosis and is involved in the development of EBI after SAH.Entities:
Keywords: Brain iron metabolism; C/EBP homologous protein; CHOP; Early brain injury; Endoplasmic reticulum stress; Hepcidin; Subarachnoid hemorrhage
Mesh:
Substances:
Year: 2017 PMID: 29291402 DOI: 10.1016/j.expneurol.2017.12.015
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330